APO Research
Talk to an analyst

APO RESEARCH · REPORT

Irritable Bowel Syndrome (IBS)

Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.

Selected research

Industry Growth & Trends

Global Irritable Bowel Syndrome (IBS) Industry Growth and Trends Forecast to 2032

26 December 202589 pages

Choose your research edition.

Industry ResearchIrritable Bowel Syndrome (IBS) Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Irritable Bowel Syndrome (IBS) Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal Irritable Bowel Syndrome (IBS) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Irritable Bowel Syndrome (IBS) Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Irritable Bowel Syndrome (IBS) Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.

According to APO Research, the global Irritable Bowel Syndrome (IBS) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Irritable Bowel Syndrome (IBS) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Irritable Bowel Syndrome (IBS) market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Irritable Bowel Syndrome (IBS) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Irritable Bowel Syndrome (IBS).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Irritable Bowel Syndrome (IBS) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Irritable Bowel Syndrome (IBS) Market by Company

Bausch Health

Allergan

Takeda

Sucampo Pharmaceuticals (Mallinckrodt)

Sebela Pharmaceuticals Inc

Astellas Pharmaceuticals

Irritable Bowel Syndrome (IBS) Segment by Type

IBS-D Drug

IBS-C Drug

Others

Irritable Bowel Syndrome (IBS) Segment by Application

Women

Men

Irritable Bowel Syndrome (IBS) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Irritable Bowel Syndrome (IBS) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Irritable Bowel Syndrome (IBS) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Irritable Bowel Syndrome (IBS).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Irritable Bowel Syndrome (IBS) companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Irritable Bowel Syndrome (IBS) Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Irritable Bowel Syndrome (IBS) Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Irritable Bowel Syndrome (IBS) Market Share by Region (2021-2026) Table 4. Global Irritable Bowel Syndrome (IBS) Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Irritable Bowel Syndrome (IBS) Market Share by Region (2027-2032) Table 6. Global Irritable Bowel Syndrome (IBS) Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Irritable Bowel Syndrome (IBS) Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Irritable Bowel Syndrome (IBS) Market Size Share by Type (2021-2026) Table 9. Global Irritable Bowel Syndrome (IBS) Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Irritable Bowel Syndrome (IBS) Market Size Share Forecasted by Type (2027-2032) Table 11. North America Irritable Bowel Syndrome (IBS) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Irritable Bowel Syndrome (IBS) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Irritable Bowel Syndrome (IBS) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Irritable Bowel Syndrome (IBS) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Irritable Bowel Syndrome (IBS) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Irritable Bowel Syndrome (IBS) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Irritable Bowel Syndrome (IBS) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Irritable Bowel Syndrome (IBS) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Irritable Bowel Syndrome (IBS) Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Irritable Bowel Syndrome (IBS) Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Irritable Bowel Syndrome (IBS) Market Size Share by Application (2021-2026) Table 24. Global Irritable Bowel Syndrome (IBS) Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Irritable Bowel Syndrome (IBS) Market Size Share Forecasted by Application (2027-2032) Table 26. North America Irritable Bowel Syndrome (IBS) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Irritable Bowel Syndrome (IBS) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Irritable Bowel Syndrome (IBS) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Irritable Bowel Syndrome (IBS) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Irritable Bowel Syndrome (IBS) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Irritable Bowel Syndrome (IBS) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Irritable Bowel Syndrome (IBS) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Irritable Bowel Syndrome (IBS) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Irritable Bowel Syndrome (IBS) Industry Trends Table 37. Irritable Bowel Syndrome (IBS) Industry Drivers Table 38. Irritable Bowel Syndrome (IBS) Industry Opportunities and Challenges Table 39. Irritable Bowel Syndrome (IBS) Industry Restraints Table 40. Global Irritable Bowel Syndrome (IBS) Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Company (2021-2026) Table 42. Global Irritable Bowel Syndrome (IBS) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Irritable Bowel Syndrome (IBS) Key Company Headquarters & Area Served Table 44. Global Irritable Bowel Syndrome (IBS) Company, Product Type & Application Table 45. Global Irritable Bowel Syndrome (IBS) Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Irritable Bowel Syndrome (IBS) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Bausch Health Company Information Table 49. Bausch Health Business Overview Table 50. Bausch Health Irritable Bowel Syndrome (IBS) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Bausch Health Irritable Bowel Syndrome (IBS) Product Portfolio Table 52. Bausch Health Recent Development Table 53. Allergan Company Information Table 54. Allergan Business Overview Table 55. Allergan Irritable Bowel Syndrome (IBS) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Allergan Irritable Bowel Syndrome (IBS) Product Portfolio Table 57. Allergan Recent Development Table 58. Takeda Company Information Table 59. Takeda Business Overview Table 60. Takeda Irritable Bowel Syndrome (IBS) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Takeda Irritable Bowel Syndrome (IBS) Product Portfolio Table 62. Takeda Recent Development Table 63. Sucampo Pharmaceuticals (Mallinckrodt) Company Information Table 64. Sucampo Pharmaceuticals (Mallinckrodt) Business Overview Table 65. Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Product Portfolio Table 67. Sucampo Pharmaceuticals (Mallinckrodt) Recent Development Table 68. Sebela Pharmaceuticals Inc Company Information Table 69. Sebela Pharmaceuticals Inc Business Overview Table 70. Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Product Portfolio Table 72. Sebela Pharmaceuticals Inc Recent Development Table 73. Astellas Pharmaceuticals Company Information Table 74. Astellas Pharmaceuticals Business Overview Table 75. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product Portfolio Table 77. Astellas Pharmaceuticals Recent Development Table 78. North America Irritable Bowel Syndrome (IBS) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 79. North America Irritable Bowel Syndrome (IBS) Market Size by Country (2021-2026) & (US$ Million) Table 80. North America Irritable Bowel Syndrome (IBS) Market Share by Country (2021-2026) Table 81. North America Irritable Bowel Syndrome (IBS) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 82. North America Irritable Bowel Syndrome (IBS) Market Share Forecast by Country (2027-2032) Table 83. Europe Irritable Bowel Syndrome (IBS) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 84. Europe Irritable Bowel Syndrome (IBS) Market Size by Country (2021-2026) & (US$ Million) Table 85. Europe Irritable Bowel Syndrome (IBS) Market Share by Country (2021-2026) Table 86. Europe Irritable Bowel Syndrome (IBS) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 87. Europe Irritable Bowel Syndrome (IBS) Market Share Forecast by Country (2027-2032) Table 88. Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 89. Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Country (2021-2026) & (US$ Million) Table 90. Asia-Pacific Irritable Bowel Syndrome (IBS) Market Share by Country (2021-2026) Table 91. Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 92. Asia-Pacific Irritable Bowel Syndrome (IBS) Market Share Forecast by Country (2027-2032) Table 93. Latin America Irritable Bowel Syndrome (IBS) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 94. Latin America Irritable Bowel Syndrome (IBS) Market Size by Country (2021-2026) & (US$ Million) Table 95. Latin America Irritable Bowel Syndrome (IBS) Market Share by Country (2021-2026) Table 96. Latin America Irritable Bowel Syndrome (IBS) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 97. Latin America Irritable Bowel Syndrome (IBS) Market Share Forecast by Country (2027-2032) Table 98. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Country (2021-2026) & (US$ Million) Table 100. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Share by Country (2021-2026) Table 101. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Share Forecast by Country (2027-2032) Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Irritable Bowel Syndrome (IBS) Product Image Figure 3. Global Irritable Bowel Syndrome (IBS) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Irritable Bowel Syndrome (IBS) Market Size (2021-2032) & (US$ Million) Figure 5. Global Irritable Bowel Syndrome (IBS) Market Share by Region: 2025 VS 2032 Figure 6. Global Irritable Bowel Syndrome (IBS) Market Share by Region (2021-2032) Figure 7. North America Irritable Bowel Syndrome (IBS) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Irritable Bowel Syndrome (IBS) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Irritable Bowel Syndrome (IBS) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. IBS-D Drug Image Figure 13. Global IBS-D Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. IBS-C Drug Image Figure 15. Global IBS-C Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Others Image Figure 17. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Irritable Bowel Syndrome (IBS) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Irritable Bowel Syndrome (IBS) Market Share by Type 2025 VS 2032 Figure 20. North America Irritable Bowel Syndrome (IBS) Market Size Share by Type (2021-2032) Figure 21. Europe Irritable Bowel Syndrome (IBS) Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size Share by Type (2021-2032) Figure 23. Latin America Irritable Bowel Syndrome (IBS) Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Irritable Bowel Syndrome (IBS) Market Size Share by Type (2021-2032) Figure 25. Women Image Figure 26. Global Women Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Men Image Figure 28. Global Men Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global Irritable Bowel Syndrome (IBS) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Irritable Bowel Syndrome (IBS) Market Share by Application 2025 VS 2032 Figure 31. North America Irritable Bowel Syndrome (IBS) Market Size Share by Application (2021-2032) Figure 32. Europe Irritable Bowel Syndrome (IBS) Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size Share by Application (2021-2032) Figure 34. Latin America Irritable Bowel Syndrome (IBS) Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa Irritable Bowel Syndrome (IBS) Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 Irritable Bowel Syndrome (IBS) Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America Irritable Bowel Syndrome (IBS) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America Irritable Bowel Syndrome (IBS) Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America Irritable Bowel Syndrome (IBS) Market Share by Country (2021-2032) Figure 41. Europe Irritable Bowel Syndrome (IBS) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe Irritable Bowel Syndrome (IBS) Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Irritable Bowel Syndrome (IBS) Market Share by Country (2021-2032) Figure 44. Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific Irritable Bowel Syndrome (IBS) Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific Irritable Bowel Syndrome (IBS) Market Share by Country (2021-2032) Figure 47. Latin America Irritable Bowel Syndrome (IBS) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America Irritable Bowel Syndrome (IBS) Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America Irritable Bowel Syndrome (IBS) Market Share by Country (2021-2032) Figure 50. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • IBS-D Drug
  • IBS-C Drug
  • Others
Applications
  • Women
  • Men
Companies covered
  • Bausch Health
  • Allergan
  • Takeda
  • Sucampo Pharmaceuticals (Mallinckrodt)
  • Sebela Pharmaceuticals Inc
  • Astellas Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Irritable Bowel Syndrome (IBS) Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Irritable Bowel Syndrome (IBS) Market Size by Region (2021-2032)
  5. 1.4.1 Global Irritable Bowel Syndrome (IBS) Market Size by Region (2021-2026)
  6. 1.4.2 Global Irritable Bowel Syndrome (IBS) Market Size by Region (2027-2032)
  7. 1.5 Key Regions Irritable Bowel Syndrome (IBS) Market Size (2021-2032)
  8. 1.5.1 North America Irritable Bowel Syndrome (IBS) Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Irritable Bowel Syndrome (IBS) Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Irritable Bowel Syndrome (IBS) Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size Growth Rate (2021-2032)
2 Irritable Bowel Syndrome (IBS) Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 IBS-D Drug
  3. 2.1.2 IBS-C Drug
  4. 2.1.3 Others
  5. 2.2 Global Irritable Bowel Syndrome (IBS) Market Size by Type
  6. 2.2.1 Global Irritable Bowel Syndrome (IBS) Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Irritable Bowel Syndrome (IBS) Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Irritable Bowel Syndrome (IBS) Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Irritable Bowel Syndrome (IBS) Market Size by Regions
  10. 2.3.1 North America Irritable Bowel Syndrome (IBS) Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Irritable Bowel Syndrome (IBS) Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Irritable Bowel Syndrome (IBS) Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Irritable Bowel Syndrome (IBS) Market Size Breakdown by Type (2021-2026)
3 Irritable Bowel Syndrome (IBS) Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Women
  3. 3.1.2 Men
  4. 3.2 Global Irritable Bowel Syndrome (IBS) Market Size by Application
  5. 3.2.1 Global Irritable Bowel Syndrome (IBS) Market Size Overview by Application (2021-2032)
  6. 3.2.2 Global Irritable Bowel Syndrome (IBS) Historic Market Size Review by Application (2021-2026)
  7. 3.2.3 Global Irritable Bowel Syndrome (IBS) Market Size Forecasted by Application (2027-2032)
  8. 3.3 Global Irritable Bowel Syndrome (IBS) Market Size by Regions
  9. 3.3.1 North America Irritable Bowel Syndrome (IBS) Market Size Breakdown by Application (2021-2026)
  10. 3.3.2 Europe Irritable Bowel Syndrome (IBS) Market Size Breakdown by Application (2021-2026)
  11. 3.3.3 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size Breakdown by Application (2021-2026)
  12. 3.3.4 South America Irritable Bowel Syndrome (IBS) Market Size Breakdown by Application (2021-2026)
  13. 3.3.5 Middle East and Africa Irritable Bowel Syndrome (IBS) Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Irritable Bowel Syndrome (IBS) Industry Trends
  2. 4.2 Irritable Bowel Syndrome (IBS) Industry Drivers
  3. 4.3 Irritable Bowel Syndrome (IBS) Industry Opportunities and Challenges
  4. 4.4 Irritable Bowel Syndrome (IBS) Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Irritable Bowel Syndrome (IBS) Revenue (2021-2026)
  2. 5.2 Global Irritable Bowel Syndrome (IBS) Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Irritable Bowel Syndrome (IBS) Key Company Headquarters & Area Served
  4. 5.4 Global Irritable Bowel Syndrome (IBS) Company, Product Type & Application
  5. 5.5 Global Irritable Bowel Syndrome (IBS) Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Irritable Bowel Syndrome (IBS) Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Irritable Bowel Syndrome (IBS) Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Irritable Bowel Syndrome (IBS) Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Bausch Health
  2. 6.1.1 Bausch Health Company Information
  3. 6.1.2 Bausch Health Business Overview
  4. 6.1.3 Bausch Health Irritable Bowel Syndrome (IBS) Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Bausch Health Irritable Bowel Syndrome (IBS) Product Portfolio
  6. 6.1.5 Bausch Health Recent Developments
  7. 6.2 Allergan
  8. 6.2.1 Allergan Company Information
  9. 6.2.2 Allergan Business Overview
  10. 6.2.3 Allergan Irritable Bowel Syndrome (IBS) Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Allergan Irritable Bowel Syndrome (IBS) Product Portfolio
  12. 6.2.5 Allergan Recent Developments
  13. 6.3 Takeda
  14. 6.3.1 Takeda Company Information
  15. 6.3.2 Takeda Business Overview
  16. 6.3.3 Takeda Irritable Bowel Syndrome (IBS) Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Takeda Irritable Bowel Syndrome (IBS) Product Portfolio
  18. 6.3.5 Takeda Recent Developments
  19. 6.4 Sucampo Pharmaceuticals (Mallinckrodt)
  20. 6.4.1 Sucampo Pharmaceuticals (Mallinckrodt) Company Information
  21. 6.4.2 Sucampo Pharmaceuticals (Mallinckrodt) Business Overview
  22. 6.4.3 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Product Portfolio
  24. 6.4.5 Sucampo Pharmaceuticals (Mallinckrodt) Recent Developments
  25. 6.5 Sebela Pharmaceuticals Inc
  26. 6.5.1 Sebela Pharmaceuticals Inc Company Information
  27. 6.5.2 Sebela Pharmaceuticals Inc Business Overview
  28. 6.5.3 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Product Portfolio
  30. 6.5.5 Sebela Pharmaceuticals Inc Recent Developments
  31. 6.6 Astellas Pharmaceuticals
  32. 6.6.1 Astellas Pharmaceuticals Company Information
  33. 6.6.2 Astellas Pharmaceuticals Business Overview
  34. 6.6.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product Portfolio
  36. 6.6.5 Astellas Pharmaceuticals Recent Developments
7 North America
  1. 7.1 North America Irritable Bowel Syndrome (IBS) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Irritable Bowel Syndrome (IBS) Market Size by Country (2021-2026)
  3. 7.3 North America Irritable Bowel Syndrome (IBS) Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Irritable Bowel Syndrome (IBS) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Irritable Bowel Syndrome (IBS) Market Size by Country (2021-2026)
  3. 8.3 Europe Irritable Bowel Syndrome (IBS) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Irritable Bowel Syndrome (IBS) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Irritable Bowel Syndrome (IBS) Market Size by Country (2021-2026)
  3. 10.3 South America Irritable Bowel Syndrome (IBS) Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst